The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Self-citationPalella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,350
Measurement of gastrointestinal pH profiles in normal ambulant human subjects
Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., & Hardcastle, J. D. (1988) · Gut · doi:10.1136/gut.29.8.1035 · Cited by 1,240
Department of Health and Human Services
(2002) · Handbook of Research Design & Social Measurement · doi:10.4135/9781412984386.n104 · Cited by 1,032
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Self-citationBDDCS Applied to Over 900 Drugs
Benet, L. Z., Broccatelli, F., & Oprea, T. I. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9290-9 · Cited by 626
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Mechanism of Active Renal Tubular Efflux of Tenofovir
Ray, A. S., Cihlar, T., Robinson, K. L., Tong, L., Vela, J. E., Fuller, M. D., Wieman, L. M., Eisenberg, E. J., & Rhodes, G. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00251-06 · Cited by 323
van Lunzen, J., Maggiolo, F., Arribas, J. R., Rakhmanova, A., Yeni, P., Young, B., Rockstroh, J. K., Almond, S., Song, I., Brothers, C., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70290-0 · Cited by 301
Hesselink, D. A., van Hest, R. M., Mathôt, R. A. A., Bonthuis, F., Weimar, W., de Bruin, R. W. F., & van Gelder, T. (2005) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2005.00779.x · Cited by 300
Zhang, D., Chando, T. J., Everett, D. W., Patten, C. J., Dehal, S. S., & Humphreys, W. G. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005447 · Cited by 286
Ito, K., Iwatsubo, T., Kanamitsu, S., Nakajima, Y., & Sugiyama, Y. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.461 · Cited by 282
Kassahun, K., McIntosh, I., Cui, D., Hreniuk, D., Merschman, S., Lasseter, K., Azrolan, N., Iwamoto, M., Wagner, J. A., & Wenning, L. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016196 · Cited by 278
Rautio, J., Humphreys, J. E., Webster, L. O., Balakrishnan, A., Keogh, J. P., Kunta, J. R., Serabjit-Singh, C. J., & Polli, J. W. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008615 · Cited by 260
Self-citationMin, S., Song, I., Borland, J., Chen, S., Lou, Y., Fujiwara, T., & Piscitelli, S. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00842-09 · Cited by 244
Polli, J. W., Humphreys, J. E., Harmon, K. A., Castellino, S., O’Mara, M. J., Olson, K. L., John-Williams, L. S., Koch, K. M., & Serabjit-Singh, C. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018374 · Cited by 243
Self-citationChen, Y., Tang, Y., Guo, C., Wang, J., Boral, D., & Nie, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.030 · Cited by 219
Kusuhara, H., Ito, S., Kumagai, Y., Jiang, M., Shiroshita, T., Moriyama, Y., Inoue, K., Yuasa, H., & Sugiyama, Y. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.36 · Cited by 217
Lui, C. Y., Amidon, G. L., Berardi, R. R., Fleisher, D., Youngberg, C., & Dressman, J. B. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750313 · Cited by 201
Yeh, R. F., Gaver, V. E., Patterson, K. B., Rezk, N. L., Baxter-Meheux, F., Blake, M. J., Eron, J. J., Klein, C. E., Rublein, J. C., & Kashuba, A. D. M. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000219774.20174.64 · Cited by 194
Hariparsad, N., Nallani, S. C., Sane, R. S., Buckley, D. J., Buckley, A. R., & Desai, P. B. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004269142 · Cited by 192
A regulatory viewpoint on transporter-based drug interactions
Zhang, L., Zhang, Y. (. )., Strong, J. M., Reynolds, K. S., & Huang, S.-M. (2008) · Xenobiotica · doi:10.1080/00498250802017715 · Cited by 188
Ritonavir-boosted protease inhibitors in HIV therapy
Hull, M. W., & Montaner, J. S. G. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.572905 · Cited by 160
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
Benet, L. Z., Amidon, G. L., Barends, D. M., Lennernäs, H., Polli, J. E., Shah, V. P., Stavchansky, S. A., & Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9523-x · Cited by 147
Self-citationEffect of dronedarone on renal function in healthy subjects
Tschuppert, Y., Buclin, T., Rothuizen, L. E., Decosterd, L. A., Galleyrand, J., Gaud, C., & Biollaz, J. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02998.x · Cited by 122
Functional interaction of intestinal CYP3A4 and P‐glycoprotein
Kivistö, K. T., Niemi, M., & Fromm, M. F. (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00291.x · Cited by 120
Granfors, M. T., Wang, J., Kajosaari, L. I., Laitila, J., Neuvonen, P. J., & Backman, J. T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_249.x · Cited by 112
Atazanavir for the Treatment of Human Immunodeficiency Virus Infection
Busti, A. J., Hall, R. G., & Margolis, D. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.17.1732.52347 · Cited by 111
Bowen, W. P., Carey, J. E., Miah, A., McMurray, H. F., Munday, P. W., James, R. S., Coleman, R. A., & Brown, A. M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15348-2 · Cited by 109
Imamura, Y., Murayama, N., Okudaira, N., Kurihara, A., Okazaki, O., Izumi, T., Inoue, K., Yuasa, H., Kusuhara, H., & Sugiyama, Y. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.232 · Cited by 108
Collier, A. C., Tingle, M. D., Keelan, J. A., Paxton, J. W., & Mitchell, M. D. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12047-0 · Cited by 81
Hinton, L. K., Galetin, A., & Houston, J. B. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9446-6 · Cited by 74
Song, I. H., Borland, J., Min, S., Lou, Y., Chen, S., Patel, P., Wajima, T., & Piscitelli, S. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00073-11 · Cited by 72
Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro
Zembruski, N. C. L., Büchel, G., Jodicke, L., Herzog, M., Haefeli, W. E., & Weiss, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq501 · Cited by 67
Song, I. H., Borland, J., Chen, S., Lou, Y., Peppercorn, A., Wajima, T., Min, S., & Piscitelli, S. C. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03947.x · Cited by 66
Song, I. H., Min, S., Borland, J., Lou, Y., Chen, S., Patel, P., Ishibashi, T., & Piscitelli, S. C. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010371113 · Cited by 58
Dofetilide: a new class III antiarrhythmic agent
Roukoz, H., & Saliba, W. I. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.1.9 · Cited by 52
Polli, J. W., Hussey, E. K., Bush, M., Generaux, G. T., Smith, G. A., Collins, D., McMullen, S. L., Turner, N., & Nunez, D. J. (2012) · Xenobiotica · doi:10.3109/00498254.2012.739719 · Cited by 49
Self-citationYanakakis, L. J., & Bumpus, N. N. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.044404 · Cited by 46
Song, I. H., Min, S., Borland, J., Lou, Y., Chen, S., Ishibashi, T., Wajima, T., & Piscitelli, S. C. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e67909 · Cited by 35
Cited by
Cottrell, M. L., Hadzic, T., & Kashuba, A. D. M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0093-2 · Cited by 298
Organic Cation Transporters in Health and Disease
Koepsell, H. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015578 · Cited by 297
Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters
Nigam, S. K., Wu, W., Bush, K. T., Hoenig, M. P., Blantz, R. C., & Bhatnagar, V. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02440314 · Cited by 269
Ford, S. L., Gould, E., Chen, S., Margolis, D., Spreen, W., Crauwels, H., & Piscitelli, S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01235-13 · Cited by 83
Zeng, F., Wang, F., Zheng, Z., Chen, Z., Wah To, K. K., Zhang, H., Han, Q., & Fu, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.008 · Cited by 26
Metadata
- Authors
- Reese, M. J., Savina, P. M., Generaux, G. T., Tracey, H., Humphreys, J. E., Kanaoka, E., Webster, L. O., Harmon, K. A., Clarke, J. D., & Polli, J. W.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 41
- Issue
- 2
- Pages
- 353-361
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2151589354
- Cited by
- 254
- References
- 42
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.